|
| |
Investment in the pharmaceutical and biotechnology industries remains robust and is becoming more global, fueled in part by the global need for vaccine manufacturing capacity. Biopharmaceutical products remain a significant area of development for many of our clients.
As companies in the pharmaceuticals industry continue to experience pressure to decrease product time-to-market, reduce costs, and increase return on investment, the types of services we provide have grown to include modular construction, consulting, and strategic planning to help our clients complete capital projects faster and more efficiently. We also integrate commissioning and validation services, helping reduce the amount of time required to introduce a new drug into the marketplace.
Furthermore, India and Eastern Europe are witnessing both increased inward investment and rapidly growing populations. Our local operations in these areas enhance our abilities to undertake projects for such investors.
Continued strong investment in the global process industries is expected in the years to come, and we remain unconditionally committed to the growth and success of our clients in the pharmaceutical and biotechnology industries.
|
|